Search

everythinglearnresearchcommunity

for

Search:↓

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Sorafenib can cause a unique skin reaction.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

A man regrew hair after using a specific cream for skin treatment.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Bortezomib chemotherapy can cause temporary skin rashes.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

The conclusion is unclear about minoxidil's effectiveness for preventing hair loss from chemotherapy.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Etoposide makes radiation therapy more effective against tumors without major side effects.